Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

S 2537 requires manufacturers and retailers of hemp-derived cannabinoid products (like Delta-8-THC edibles, vapes, and cosmetics) to register with New Jersey’s Cannabis Regulatory Commission and comply with safety testing, labeling, and content disclosure rules. It directly affects businesses selling these products, which currently operate outside regulated cannabis/hemp frameworks despite containing psychoactive compounds that may exceed legal THC limits. Key provisions mandate product testing for safety and potency, clear labeling of cannabinoid content (including Delta-8-THC), and registration to track products not meeting existing hemp regulations. The bill aims to address safety concerns raised by independent tests showing some products contain dangerously high THC levels and untested isomers.